E-Mail
IMAGE: Dr. Elizabeth Morrison-Banks is a health sciences clinical professor of neurology at UC Riverside. view more
Credit: C. Rosema.
RIVERSIDE, Calif. A survey of U.S. multiple sclerosis, or MS, specialist clinicians reveals the COVID-19 pandemic has created major changes in how they deliver care. Since the pandemic began, more than 95% of our survey respondents reported using telehealth platforms to provide care for their patients, said Dr. Elizabeth Morrison-Banks, a health sciences clinical professor of neurology in the School of Medicine at the University of California, Riverside, who led the survey reported in the journal
Multiple Sclerosis and Related Disorders. Approximately one half of the respondents were MS specialist neurologists, four out of five of whom indicated that COVID-19 had changed how they were recommending and prescribing MS disease-modifying therapies.